-

Eurofins Publishes Method for Early Detection of Asymptomatic SARS-CoV-2 Virus Spreaders, That Does Not Require Human PCR Clinical Testing

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins (Paris:ERF):

Although employees showing COVID-19 symptoms are currently discouraged from going to work, significant workplace COVID-19 outbreaks continue to occur. Virus spread by asymptomatic SARS-CoV-2 infected individuals has been reported to be a significant cause of contamination clusters. Yet, other than PCR testing every employee each day using an invasive nasal or nasopharyngeal swab, few options exist to detect asymptomatic virus spreaders who can contaminate other employees or visitors.

Following an extensive study (1) involving over 6,300 PCR tests at nine office and industrial locations in Europe and North America, Eurofins demonstrated that its Eurofins COVID-19 SentinelTM RT-PCR environmental surfaces tests can contribute to detecting asymptomatic virus spreaders.

Eurofins is launching Eurofins COVID-19 SentinelTM worldwide today as part of its SAFER@WORK™ programme. Through a comprehensive range of testing solutions, including waste water testing, work environment surface testing and worn mask testing, Eurofins COVID-19 Sentinel™ provides an early warning of the presence of SARS-CoV-2 at a given site (e.g. a city, factories, education, government and public service sites, nursing homes), before the virus spreads too broadly. If positive results are found employees present in the rooms tested can be isolated and advised to get tested by clinical RT-PCR.

In response to the COVID-19 pandemic, governments and employers have deployed a set of measures to control the spread of the SARS-CoV-2 virus in workplaces including regular employee testing. Due to barriers to personal testing, such as inconvenience, expense and invasiveness, businesses, education, public and government bodies are looking for non-invasive cost-effective ways for early outbreak detection.

This is why Eurofins developed the Eurofins COVID-19 SentinelTM programme, which is affordable, easily organised and non-invasive. It allows governments and companies to early detect the presence of asymptomatic and pre-symptomatic virus carriers, at times before anyone is aware of the issue, and to assess effectiveness of workplace COVID-19 management plans.

(1) Sentinel Coronavirus Environmental Monitoring Can Contribute to Detecting Asymptomatic SARS-CoV-2 Virus Spreaders and Can Verify Effectiveness of Workplace COVID-19 Controls https://medrxiv.org/cgi/content/short/2020.06.24.20131185v1

The full release can be found at: https://www.eurofins.com/media-centre/press-releases/2020-07-01_2/

For further information, please visit www.eurofins.com

About Eurofins, the global leader in Bioanalysis
With over 47,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Contacts

Yvoine McCort
ir@eurofins.com

Eurofins Scientific

BOURSE:ERF

Release Versions

Contacts

Yvoine McCort
ir@eurofins.com

More News From Eurofins Scientific

Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples

LYON, France--(BUSINESS WIRE)--Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples. This innovation underlines Eurofins Biomnis’ diagnostic innovation, and its commitment to contributing its expert...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd March to 06th March 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 30 000 67.7739 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 10 000 67.7248 CEUX EUROFINS SCIENTIFIC 529900JEHFM...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 2. Identi...
Back to Newsroom